| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $398K | — | +4.5% |
| Cost of Revenue | $134K | — | +26.4% |
| Gross Profit | $264K | — | -4.0% |
| R&D Expense | $2.3M | — | -7.8% |
| SG&A Expense | $2.7M | — | -7.5% |
| Operating Income | -$4.8M | — | +7.8% |
| Income Tax | $0 | — | — |
| Net Income | -$4.7M | — | +5.5% |
| EPS (Basic) | -$0.19 | — | +44.1% |
| EPS (Diluted) | -$0.19 | — | +44.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $15.8M | +238.1% | +10.0% |
| Accounts Receivable | $68K | -34.6% | +134.5% |
| Current Assets | $16.9M | +209.2% | +10.3% |
| Total Assets | $21.2M | +106.7% | +1.7% |
| Current Liabilities | $4.3M | +6.3% | +59.5% |
| Total Liabilities | $5.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.4M | — | +7.0% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | -$20K | — | +86.7% |
| Financing Cash Flow | $15.5M | — | — |
| Free Cash Flow | -$4.4M | — | +7.5% |
| +40.5% |
| Stockholders' Equity | $16.0M | +182.4% | -6.6% |